HALO logo
halo search icon
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc.
CPRX · NAS

Catalyst Pharmaceuticals, Inc.

US$31.25

Price Arrow0.04 (0.128%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHALO Price MomentumVolume Spike
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Catalyst Pharmaceuticals, Inc. Overview

CPRX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Strong

Garp

Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CPRX

icon

Telephone

1.305.420.3200

icon

Address

Suite 801, 355 Alhambra Circle, Coral Gables, FL 33134

Description

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

CPRX Price Chart

Key Stats

Market Cap

US$3.82B

PE

13.90

EV/EBITDA

7.6

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 19.05 - 32.56

Trade Value (12mth)

US$9,039,950.00

1 week

0.1%

1 month

21.72%

YTD

34.82%

1 year

28.33%

All time high

32.56

Key Fundamentals

EPS 3 yr Growth

118.10%

EBITDA Margin

50.20%

Operating Cashflow

$209m

Free Cash Flow Return

24.70%

ROIC

25.40%

Interest Coverage

0.00

Quick Ratio

5.80

Other Data

Shares Outstanding (Fully Diluted)

127m

HALO Sector

Healthcare

Next Company Report Date

17-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CPRX Announcements

Latest Announcements

DateAnnouncements
12 May 26
12 May 26
12 May 26
07 May 26
07 May 26

CPRX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock0.671.381.75locklocklock
EPS (Fully Diluted)
$locklocklocklock0.631.311.68locklocklock
Growth
%locklocklocklock-16.4105.926.7locklocklock
PE
Xlocklocklocklock26.815.913.9locklocklock
EV/EBITDA
Xlocklocklocklock14.897.6locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Catalyst Pharmaceuticals, Inc. (CPRX:NAS)?
Halo FAQ
The current share price of Catalyst Pharmaceuticals, Inc. (CPRX:NAS) is USD$31.25.
What is the 52-week high share price for Catalyst Pharmaceuticals, Inc. (CPRX:NAS)?
Halo FAQ
The 52-week high share price for Catalyst Pharmaceuticals, Inc. (CPRX:NAS) is USD$32.56.
What is the 52-week low share price for Catalyst Pharmaceuticals, Inc. (CPRX:NAS)?
Halo FAQ
The 52-week low share price for Catalyst Pharmaceuticals, Inc. (CPRX:NAS) is USD$19.05.
What is the dividend yield for Catalyst Pharmaceuticals, Inc. (CPRX:NAS)?
Halo FAQ
Catalyst Pharmaceuticals, Inc. (CPRX:NAS) does not pay a dividend.
What was Catalyst Pharmaceuticals, Inc. (CPRX:NAS) last dividend payment?
Halo FAQ
Catalyst Pharmaceuticals, Inc. (CPRX:NAS) does not pay a dividend.
What is the franking level for Catalyst Pharmaceuticals, Inc. (CPRX:NAS)?
Halo FAQ
Catalyst Pharmaceuticals, Inc. (CPRX:NAS) has a franking level of 0.00%.
In which sector is Catalyst Pharmaceuticals, Inc. (CPRX:NAS) classified?
Halo FAQ
Catalyst Pharmaceuticals, Inc. (CPRX:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Catalyst Pharmaceuticals, Inc. (CPRX:NAS)?
Halo FAQ
The current P/E ratio for Catalyst Pharmaceuticals, Inc. (CPRX:NAS) is 13.90.

See beyond the curve.

One solution for research, investing and portfolio management.